Which intracranial lesions would be suitable for 5-aminolevulenic acid-induced fluorescence-guided identification, localization, or resection? A prospective study of 114 consecutive intracranial lesions

Clinical Neurosurgery

Volumn 56, Issue , 2009, Pages 93-97

  Eljamel, M Sam ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; GALLIUM; PROTOPORPHYRIN; DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT;

ARTICLE; BRAIN BIOPSY; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL TRIAL; ENDOSCOPE; EQUIPMENT DESIGN; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPE; GALLIUM NITRIDE LASER; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LASER; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPECTROMETER; BRAIN TUMOR; COMPUTER ASSISTED SURGERY; FOLLOW UP; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SPECTROFLUOROMETRY; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 77952313127     PISSN: 00694827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Amar AP, Hinton DR, Krieger MD, Weiss MH: Invasive pituitary adenomas: Significance of proliferation parameters. Pituitary 2:117-122, 1999.
2. Anson JA, Segal MN, Baldwin NG, Neal D: Resection of giant invasive pituitary tumors through a transfacial approach: Technical case report. Neurosurgery 37:545-546, 1995.
3. Bonelli FS, Huston J 3rd, Carpenter PC, Erickson D, Young WF Jr, Meyer FB: Adrenocorticotropic hormone-dependent Cushing's syndrome: Sensitivity and specificity of inferior petrosal sinus sampling. AJNR Am J Neuroradiol 21:690-696, 2000.
4. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78:767-775, 1993.
5. Eljamel MS. Fluorescence image-guided surgery of brain tumors: Explained step-by-step. Photodiagnosis Photodyn Ther 5:260-263, 2008.
6. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescenceguided resection and repetitive PDT in glioblastoma multiforme: A single centre Phase III randomised controlled trial. Lasers Med Sci 23:361-367, 2008.
7. Indrajit IK, Chidambaranathan Sundar NK, Ahmed I: Value of dynamic MRI imaging in pituitary adenomas. Neuroradiology 11:185-190, 2001.
8. Majós C, Coll S, Aguilera C, Acebes JJ, Pons LC: Imaging of giant pituitary adenomas. Neuroradiology 40:651-655, 1998.
9. Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neuro- surg 96:195-208, 2002.
10. Obwegeser A, Ortler M, Seiwald M, H. Ulme H, Kostron H: Therapy of Glioblastoma multiforme, a cumulative experience of 10 years. Acta Neurochir (Wien) 137:29-33, 1995.
11. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL: Petrosal sinus sampling with and without corticotrophin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905, 1991.
12. Oruçkaptan HH, Senmevsim O, Ozcan OE, Ozgen T: Pituitary adenomas: Results of 684 surgically treated patients and review of the literature. Surg Neurol 53:211-219, 2000.
13. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79:2282-2308, 1997. (Pubitemid 27251011)
14. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulenic acid-induced porphyrins: A prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013, 2000.
15. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group: Fluorescence-guided surgery with 5-aminolevulininc acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006.
16. Tonn JC, Stummer W. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: Practical use, risks, and pitfalls. Clin Neurosurg 55:20-26, 2008.